LOS ANGELES–(BUSINESS WIRE)–Exym, a leader in EHR software for behavioral health serving agencies across California, announced the launch of their new product Exym Engage – a set of thoughtfully curated tools to support remote work and virtual client care with electronic signatures, secure document exchange, and unlimited telehealth. The Exym Engage experience brings a robust set of features that providers can use to provide consistent mental health and human services both in-person and remotely, with new workflows designed to help comply with the new CURES Act requirements for making records accessible to patients upon request.
“Over the last year we’ve seen our customers navigate a major shift in how they use technology to deliver care when clients and staff aren’t always face-to-face,” says Beth Berger, CEO of Exym. “We designed Exym Engage to replicate the in-person experience as much as possible, creating an all-in-one solution that allows clinicians to move through their daily tasks from one centralized location. Exym Engage simplifies the virtual workflow so our customers can focus on what they do best: delivering great care.”
The new Exym Engage product includes the ability to:
“We evaluated many different telehealth tools, and believe Mend stands head and shoulders above more generic videoconferencing – because it’s thoughtfully designed for the needs of our providers,” says Paolo Bettoni, Chief Product Officer of Exym.
Learn more and sign up for Exym Engage by visiting https://exym.com/features/exym-engage/.
About Exym
Exym is a leader in EHR software for behavioral health agencies. We proudly serve agencies across California with our intuitive, robust behavioral health EHR system. 45,000+ clients per month are served by clinicians who use Exym’s EHR software to simplify their billing, documenting, and case management needs. As an EHR company in California, Exym is built to meet California’s unique needs and regulations. For more information, visit www.exym.com.
Contacts
Jessica Carey
Exym
JCarey@exym.com
GSK acquires full rights to develop, manufacture and commercialize globally mRNA candidate vaccines for influenza…
Strategic restructuring includes a workforce reduction of approximately 30%, re-focusing on research, development, and innovation…
HALIFAX, NS / ACCESSWIRE / July 2, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today…
Burlington, Ontario--(Newsfile Corp. - July 2, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT"…
NEW YORK, July 2, 2024 /PRNewswire/ -- The global load monitoring systems market size is…
ATLANTA, July 2, 2024 /PRNewswire/ -- Aveanna Healthcare ("Aveanna") has learned of a data security…